Early development of human lymphomas in a prostate cancer xenograft program using triple knock‐out Immunocompromised mice

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|6|585-592

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.6, 2015-05, pp. : 585-592

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Altered miRNA expression patterns in Tff2 knock-out mice correlate with cellular pathways of neoplastic development and caloric metabolism

By            

International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-01 ,pp. : 637-643

Spandidos Publications

Access to resources Recommend Favorite

Adjuvant Hormonal Treatment for Prostate Cancer: The Bicalutamide Early Prostate Cancer Program

By  

Oncology, Vol. 65, Iss. 1, 2003-09 ,pp. : 1-4

Karger

Access to resources Recommend Favorite

Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude mice

By  

THE PROSTATE, Vol. 75, Iss. 6, 2015-05 ,pp. : 593-602

John Wiley & Sons Inc

Access to resources Recommend Favorite

A role for glucocorticoid-signaling in depression-like behavior of gastrin-releasing peptide receptor knock-out mice

By Monje Francisco J.   Kim Eun-Jung   Cabatic Maureen   Lubec Gert   Herkner Kurt R.   Pollak Daniela D.  

Annals of Medicine, Vol. 43, Iss. 5, 2011-08 ,pp. : 389-402

Informa Healthcare

Access to resources Recommend Favorite

C1q Knock-Out Mice for the Study of Complement Deficiency in Autoimmune Disease

By  

Experimental and Clinical Immunogenetics, Vol. 15, Iss. 4, 1999-03 ,pp. : 231-234

Karger

Access to resources Recommend Favorite